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Abstract
Objectives This longitudinal cohort study aims to assess the extent and patterns of seroprevalence of severe acute res-
piratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in school-attending children, and their parents and school
personnel. It will examine risk factors for infection, the relationship between seropositivity and symptoms, and temporal
persistence of antibodies.
Methods The study (Ciao Corona) will enroll a regionally representative, random sample of schools in the canton of
Zurich, where 18% of the Swiss population live. Children aged 5–16 years, attending primary and secondary schools, and
their parents and school personnel are invited. Venous blood and saliva samples are collected for serological testing in
June/July 2020, in October/November 2020, and in March/April 2021. Bi-monthly questionnaires will cover SARS-CoV-2
symptoms and tests, health, preventive behavior, and lifestyle information. Hierarchical Bayesian logistic regression
models will account for sensitivity and specificity of the serological tests in the analyses and complex sampling structure,
i.e., clustering within classes and schools.
Results and conclusions This unique school-based study will allow describing temporal trends of immunity, evaluate
effects of preventive measures and will inform goal-oriented policy decisions during subsequent outbreaks.
Trial registration ClinicalTrials.gov Identifier: NCT04448717, registered June 26, 2020. https://clinicaltrials.gov/ct2/
show/NCT04448717.
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Introduction
Decisions on school openings or closures during the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic vary greatly across and within countries. While
some countries kept schools mostly open (e.g., Sweden,
Australia) or reopened early (e.g., Denmark), others opted
for prolonged closures with decisions on reopening
pending (e.g., the USA, Italy, Ireland). Early school
closures in response to the pandemic were partly guided
by evidence of transmission of other viruses, such as
influenza (Cauchemez et al. 2009; Litvinova et al. 2019),
but the current reports suggest that the susceptibility and
transmissibility of children may be largely different for
SARS-CoV-2 (Viner et al. 2020). Lower prevalence of
SARS-CoV-2 infection is reported in younger children,
which could potentially be explained by less frequent
infection or underestimation due to more frequently
asymptomatic infection course (Stringhini et al. 2020;
Gudbjartsson et al. 2020; Pollán et al. 2020). Although
children may infect others less often than adults, their
exact role in transmission pathways is still not clear (Lee
and Raszka 2020).
Several studies have reported population-level sero-
prevalence of SARS-CoV-2, including the subpopulation
of children, reflecting the cumulative incidence proportion
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of the infection (Stringhini et al. 2020; Pollán et al. 2020).
Such studies focused on households, leaving the roles of
schools in SARS-CoV-2 transmission unclear, especially as
they were often conducted during school closures. As most
of school-aged children and adolescents’ social interactions
take place in family and school (Mossong et al. 2008),
schools could play a crucial role in spreading the infection.
However, most evidence of SARS-CoV-2 infection spread
in schools currently comes from anecdotal reports and case
studies (National Centre for Immunisation Research and
Surveillance (NCIRS) 2020; Fontanet et al. 2020).
Many schools were or are still closed worldwide in
response to the pandemic, without solid arguments for or
sufficient understanding of potential consequences of
school closure policies (Masonbrink and Hurley 2020;
Silverman et al. 2020). 1.6 billion learners worldwide (90%
of all) were affected by school closure (UNESCO 2020). In
the USA, school closures were coordinated on state and
district level, with all USA public schools eventually
closing from March 25, 2020 (Education Week 2020). In
Switzerland, schools were closed from March 16 to May
10, 2020 (switching from regular in-person interaction to
home and online schooling), then partly reopened until
June 7 (e.g., teaching in half-classes, restricting larger
group activities), when regular teaching resumed again
(Swiss National COVID-19 Science Task Force 2020).
There is an urgent need for representative, population-
based studies on children and adolescents, especially in
school settings, to answer questions about prevalence,
infection routes, asymptomatic cases, risk factors, and
duration of immunity to SARS-CoV-2 infection. This
article reports on the design and protocol of a longitudinal
school-based seroprevalence study conducted in Zurich,
the largest canton of Switzerland. The study is part of a
larger nationally coordinated research network Corona
Immunitas, and one of the first and largest representative
studies of SARS-CoV-2 spread in children and adolescents
in schools, globally.
Methods
Study overview, design and population
Study objectives
The study focuses on the seroprevalence and potential
clustering of SARS-CoV-2 infection in children and ado-
lescents attending school, as well as history, symptoms,
and risk factors for SARS-CoV-2, health, lifestyle, and
quality of life outcomes. It aims to address the following
objectives:
1 To repeatedly determine the seroprevalence of SARS-
CoV-2 antibodies in school-aged children covering
grades one to eight (approximately 6–16 years old) in
June/July 2020 (after the semi-lockdown and the
subsequent reopening of schools), in October/Novem-
ber 2020 (3 months after the start of the next school
year), and in March/April 2021 (after winter).
2 To examine clustering of seropositive cases within
classes, schools and districts, and temporal evolution of
the clusters.
3 To determine the proportion of asymptomatic children
and adolescents with SARS-CoV-2 antibodies.
4 To determine the duration of the acquired immunity by
examining new infections in children with positive
serology and temporal persistence of detectable SARS-
CoV-2 antibodies.
5 To identify sociodemographic, exposure, hygiene,
school- and family-based behavioral and environmen-
tal risk factors for SARS-CoV-2 infection;
6 To assess how school-children and their families adjust
their lives and adopt preventive measures for SARS-
CoV-2 over extended periods of time.
7 To assess how quality of life is affected by the
epidemic and preventive measures imposed or recom-
mended by health authorities.
8 To assess how schools adopt preventive measures for
SARS-CoV-2 infection over extended periods of time,
and how they influence the infection rate;
9 To assess seroprevalence, clustering, and possible
routes of transmission to and from children, school
personnel, and parents.
Study design
This is a longitudinal, population-based observational study
in a regionally representative cohort of children and ado-
lescents from randomly selected schools and classes in the
canton of Zurich, Switzerland. The study is embedded in a
Swiss-wide research program Corona Immunitas (www.
corona-immunitas.ch), where another 25’000 persons
(mostly adults) will be enrolled in over 20 prospective
studies with fully aligned study protocols (West et al. 2020).
Children participants were enrolled from June 16 to July
9, 2020, whereas parents and school personnel are enrolled
from August 20 to September 5. The follow-up of the en-
rolled classes of children, their parents, and school per-
sonnel is planned until April 2021.
The longitudinal design allows for monitoring the evo-
lution of the epidemic, as well as the impact of school-
based and other preventive measures. We pre-defined three
phases, with the possibility for adaptation (i.e., adding
Phase IV) according to the dynamic of the pandemic:
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• Phase I (June to September 2020): Baseline estimate of
seroprevalence of SARS-Cov-2 in school-children,
parents, and school personnel shortly after the lock-
down and subsequent reopening of schools.
• Phase II (October/November 2020): Estimate of sero-
prevalence in the same cohort of children after the
summer holiday and 3 months of school.
• Phase III (March/April 2021): Estimate of seropreva-
lence in the same cohort of children, parents and school
personnel after the winter season.
Study setting: primary and secondary schools
in Switzerland
One out of six (1.5 million) inhabitants of Switzerland live
in the canton of Zurich. The canton is divided into 12
districts (Fig. 1). Primary school is divided into lower level
(‘‘Unterstufe’’) with grades 1–3 (kindergarten not inclu-
ded in this study) and middle level (‘‘Mittelstufe’’) with
grades 4–6. Secondary school comprises upper level
(‘‘Oberstufe’’) with grades 7–9. A significant proportion of
schools, particularly in rural setting, adopt age-mixed
learning methodology, in which students of two or three
adjacent grades are taught in the same classroom.
Further details on population characteristics and the
school system are provided in the online data supplement.
Ethical aspects
The study was approved by the Cantonal Ethics Committee
Zurich (2020-01336). Written informed consent is obtained
from parents or legal guardians (referred to as parents
further on) of participating children. Children aged
14 years and older can confirm the consent themselves.
Additional informed consent is obtained for biobanking
plasma samples for subsequent testing within the scope of
SARS-CoV-2 seroprevalence studies.
Schools: sampling and sample size
We stratified the random selection of schools within dis-
tricts of the canton, and random selection of classes was
stratified within lower, middle, and upper levels of schools.
All children attending the selected classes are invited,
except in mixed-age classes (in which only students from
the eligible grades are invited).
We selected the primary schools randomly and matched
the closest secondary school geographically. The targeted
number of schools to enroll per district ranges from 2 to 10,
depending on the district size. After the initial invitation
round, overall school participation rate is assessed and
additional schools are selected within required districts,
until the aimed number is reached, or further recruitment
would not be feasible. Population sizes and targeted
number of enrolled schools within districts are depicted in
Fig. 1.
Fig. 1 Districts of the canton of
Zurich: population density,
count, and targeted number of
enrolled schools (Switzerland,
2020)
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The overall targeted number of schools is 58 (29 pri-
mary and 29 secondary schools). We aim to invite at least 3
classes and at least 40 children per school level (lower and
middle in primary, upper in secondary schools). We will
reassess the number of classes and children to invite after
calculating the average children participation rate in the
first week of enrollment. If needed, additional classes will
be invited, aiming to enroll at least 40 children per school
level. Assuming a participation rate of 60–80% per class,
we would enroll 2100–2800 children in June/July 2020.
We expect a seroprevalence rate of 1–5% based on the
existing research (Stringhini et al. 2020). Depending on the
specificity and sensitivity parameters of the test, we expect
a precision of about ± 2%.
Population: definition
Children and adolescents residing in Switzerland and
attending a selected public or private, primary or secondary
school (approximate age 6–16 years) in the canton of
Zurich are eligible for the study, in addition to their parents
living in the same household, and the entire personnel of
participating schools. Main exclusion criteria for schools
are small school size (\ 40 children in a selected school
level), and for participants—suspected or confirmed
infection with SARS-CoV-2 during testing. School grades
1–2, 4–5, and 7–8 are included; grades 3, 6, and 9 grades
are excluded as these students may move to another school
after the summer break, and follow-up would be compro-
mised. In age-mixed learning classes in primary schools,
only grades 1 and 5 are included as children in other grades
potentially change the class after the summer break.
Detailed inclusion and exclusion criteria are provided in
the online data supplement.
Study procedures
Recruitment and study timeline
The process of recruitment and testing of children, their
parents and school personnel is depicted in Fig. 2. Ran-
domly selected schools receive an email from the study
group, including study information, a link to the study
website (www.ciao-corona.ch), informational videos in
multiple languages for schools, parents, and children.
Further details on the recruitment process are provided in
the online data supplement.
Collection of samples and testing at schools
At each of the planned testing phases, the study team will
come to the participating school for a half or full day,
depending on school size. Testing will take place in a
sufficiently large room, in small groups of participating
children, with all necessary hygiene and distancing pre-
cautions. First, information is provided, child’s identity and
consent confirmed, and saliva collected. Venous blood
samples will be collected at supine position with the help of
anesthetic patches, applied 45–60 min prior to venipunc-
ture. Participating children receive a small age-appropriate
gift (worth $5–20) at each testing.
We will invite adult participants for testing in schools or
at a testing center. Venous blood will be collected. Col-
lected samples are stored, cooled and transported to the
laboratory daily after the testing is finished.
Measurements
Summary information of specimens and questionnaires
collected is provided in Table 1.
Blood and saliva samples for serological testing
For each child and adult participant, one sample (7-9 mL
for children and 4.9 mL for adults) of venous blood will be
collected for the assessment of SARS-CoV-2 antibodies.
Plasma will be separated, aliquoted into 1 mL tubes and
biobanked at -20 C until testing.
Saliva samples are collected in clean tubes and enriched
with virus transport medium. The validity of serological
SARS-CoV-2 testing in saliva is currently not confirmed;
therefore, saliva will first be validated for serological
testing. If testing in saliva is deemed sufficiently accurate
in comparison with testing of blood, venous blood sam-
pling might not be necessary in further testing phases.
Conversely, if serological testing in saliva does not offer
sufficient accuracy, saliva sample collection will not be
continued.
For serological analysis, one or both of the following
tests will be used depending on availability, utilization in
the other nationally coordinated research program Corona
Immunitas studies and thus ability to compare the results,
and the cross-validation of the results. The first option is an
in-house developed bead-based binding assay based on the
Luminex technology. The ABCORA test (version 2.0)
provides a highly differentiated picture of the immune
response: immunoglobulins G (IgG), M (IgM), and A (IgA)
antibodies against four SARS-CoV-2 targets (receptor
binding domain (RBD), spike proteins S1 and S2, and the
nucleocapsid protein (N) of SARS-CoV-2) are analyzed,
resulting in twelve analyzed parameters. Owing to the
broad assessment of serological parameters, the ABCORA
2.0 test provides an estimate of infection recency. Based on
the ABCORA 2.0 results, the seroconversion status of a
sample will be classified as positive, weakly reactive,
indeterminate, or negative, based on pre-specified
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threshold values of detected antibody reactivities. In a
validation study (unpublished) of 104 samples of SARS-
CoV-2 reverse transcription polymerase chain reaction
(RT-PCR) positive persons and 251 samples of pre-pan-
demic, healthy blood donors, the test had sensitivity of
93.3–95.2% (compared to sensitivity of 88.5–93.3% in
commercially available tests) and specificity of
98.4–99.6% (depending on the threshold definition of
positive and negative cases).
The second option is the SenASTrIS (Sensitive Anti-
SARS-CoV-2 Spike Trimer Immunoglobulin Serological)
assay developed by the Centre Hospitalier Universitaire
Fig. 2 Timeline of study recruitment, serological testing, and follow-
up (Ciao Corona study, Switzerland, 2020–2021). Note that the
children’s questionnaire includes questions for parents. Timing of
testing and questionnaires is approximate and will depend on the
development of the pandemic
Table 1 Summary of testing and measurements in study populations (Ciao Corona study, Switzerland, 2020–2021)
Measurement School
principals












Frequency 5 times 3 times 3 timesa Bi-monthly 2 times Once 2 times Bi-monthly
Specimen







X X X X X









Quality of life X X
Lifestyle X
aFull questionnaire at baseline, shortened version at follow-up
bDepending on the results of the validation study; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
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Vaudois (CHUV), the Swiss Federal Institute of Technol-
ogy in Lausanne (EPFL) and the Swiss Vaccine Center
(Fenwick et al. 2020). The test has demonstrated 94.0%
sensitivity and 99.2% specificity for detection of SARS-
CoV-2 IgG antibodies, and up to 98.3% sensitivity and
98.4% specificity with a combined IgG and IgA test. The
test is used by all study sites of Corona Immunitas.
Collection of questionnaire data
Study participants and parents of the participating children
together with the child will fill baseline and follow-up
questionnaires online (when necessary, on paper or over
phone) (see Fig. 2). We will send follow-up questionnaires
approximately bi-monthly, adapting to the school year
timing, at least until April 2021.
The following baseline information is collected for all
participants (Table 1): sociodemographic and basic health
information; number of people in the household; SARS-
CoV-2 infection and testing related information for par-
ticipant and their household; exposures and preventive
behavior related to the pandemic within the household
since January 2020; quality of life parameters. In addition,
for the children, lifestyle, mental health and well-being
information is collected. A shortened questionnaire will be
repeated at the subsequent testing phases.
Bi-monthly follow-up of participants (Table 1) will
assess flu-like symptoms (onset, type, duration) and use of
related health-care services within the household; SARS-
CoV-2 infection test results outside this research study
within the household; adherence to preventive measures
and possible exposures (travels abroad, contact with con-
firmed SARS-Cov-2 cases, etc.) within the household.
School principals will fill in questionnaires at and
between testing phases. The following information will be
collected: total number of children per school and school
level; number of children and teachers in classes; preven-
tive measures at school organizational, infrastructure and
personnel levels. Socioeconomic status of the school will
also be estimated at baseline from official statistics.
More information on data collected with each ques-
tionnaire is provided in the online data supplement.
Study data
Data management
We will collect study data in REDCap (Research Elec-
tronic Data Capture), a secure, web-based application with
access restricted to selected study personnel. The database
will also be used to send out online surveys to school
personnel and parents and deliver study results per email.
Further details are provided in the online data supplement.
Data analysis
We will perform descriptive analysis of participant
sociodemographic, lifestyle, and behavior information.
Total seroprevalence and cumulative incidence (i.e., total
number of RT-PCR-confirmed infections in official statis-
tics per population) will be calculated and compared, as
well as age-, time-, and region-specific estimates. In order
to also include the sensitivity and specificity of the sero-
logical test in the analyses and account for the complex
sampling structure (clustering within classes and schools),
we will use hierarchical Bayesian logistic regression
models (Stringhini et al. 2020). The total numbers of
school children in the respective grades per district will be
used for post-stratification, so that the estimates are rep-
resentative for the demographics of the canton of Zurich.
We will assess the associations with health and quality
of life outcomes with multiple regression models. Other
planned estimates include proportion of seropositive indi-
viduals who have been asymptomatic, risk factors for
infection at individual and school level. We will also assess
associations of levels of IgG, IgM, and IgA antibodies with
symptoms and risk factors.
Patient and public involvement
Several school principals were consulted during the
development of the protocol to ensure feasibility of the
planned study procedures. Early feedback was collected
from children and parents invited to participate, in order to
adapt the communication strategies and channels. Further
feedback was collected from enrolled children and school
principals during the first testing phase, in order to adapt
subsequent testing phases and adult testing. Numerous
online informational sessions, encouraging open exchange
and feedback, were organized for school principals, per-
sonnel, and parents of the children. Results of individual
tests will be communicated to the participants, and overall
study results disseminated to participating schools. Find-
ings will be disseminated in lay language in the national
and local press, to the national and regional educational
and public health departments, and via the website of the
study.
Discussion
This longitudinal population-based cohort study is unique
for its focus on children and adolescents in schools. Major
policy decisions on temporary school closures or schedules
have been implemented globally in response to the pan-
demic, despite the lack of knowledge how schools con-
tribute to the spread of SARS-CoV-2 infection. This study
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will contribute to the evidence required to define the nec-
essary and sufficient preventive measures to balance
infection control and impact of school closure.
Currently available population-based seroprevalence
studies, which have included children, were mostly con-
ducted in household settings. In May 2020, only 0.8% of
children aged 5–9 years were seropositive for SARS-CoV-
2 in Geneva, Switzerland, in contrast to 9.6% of children
and adolescents aged 10–19 years and 9.9% of adults aged
20–49 years (Stringhini et al. 2020). In April and May
2020, 3.8% of children and adolescents aged 0–19 years
were seropositive in Spain, compared to 4.5–5.0% in older
age groups (Pollán et al. 2020). In contrast, the current
study will primarily consider schools. By analyzing sero-
prevalence on individual, class, and school levels, as well
as in parents and school personnel, we will be able to
identify clusters within these structures. Such knowledge
could help to decide if individual classes or whole schools
need to be closed to prevent SARS-CoV-2 infection spread.
In addition, testing the entire school personnel will con-
tribute evidence on which employees at schools are the
most susceptible to infection.
Only few related planned or ongoing studies have been
reported worldwide. In the UK, a study run by Public
Health England aims to test seroprevalence in child care
facilities and schools in England in May/June, July, and
end of autumn 2020 (Ladhani et al. 2020). However, it is
not clear if the sampling of schools will be random or
stratified by region or if the structure within schools
(classes) will be considered. A smaller study in Berlin,
Germany, aims to test 24 randomly selected schools,
including 20–40 children and adolescents (500–1000 in
total) and 5–10 staff members at each school (Charité
2020).
The results of this study will likely be generalizable to
other cantons in Switzerland and internationally, particu-
larly to high- and middle-income countries. The canton of
Zurich includes both urban and rural settings, as well as an
ethnically and linguistically diverse population. Although
the rates of seroprevalence are always location- and time-
specific, we believe that the longitudinal design will allow
us to investigate many stages of the pandemic. The wide
age range of the participants (6–16-year-old) will also
allow to detect age-based variation in seroprevalence. This
variation can be expected because risk factors, natural
history of the infection, and transmission routes might vary
by age.
Limitations
The study faces a few challenges and limitations. First,
high participation rate of schools and children is required
for sufficient power to analyze different regions and
clusters within classes and schools. We believe that the
high public interest will lead to increased participation,
which could otherwise be rather limited in a study col-
lecting venous blood samples in children. In fact, in the
initial testing phase in June/July 2020, 55 schools and more
than 2500 children were successfully enrolled. Second, the
protocol of the longitudinal study will have to be flexible as
the pandemic and serological testing methods develop. For
this reason, the specific time points of serological testing
cannot be fixed in advance (e.g., in case of school closure
during the course of the study). Similarly, in further testing
phases, serological testing in saliva or blood might be
sufficient, depending on the outcome of the validation of
serological testing in saliva. In addition, in order to recruit
a sufficient number of schools still before school summer
holidays, three rounds of invitations were needed, leading
to potential over- or under-sampling of schools in certain
districts. However, the sampling discrepancies can be
adjusted with weighing of results. Finally, although the
accuracy of the serological tests that will be used in this
study is even superior to the best commercially available
alternatives, the general knowledge on the validity and
clinical interpretation of the tests is still incomplete—
which is, partly, the motivation for this study. The inter-
pretation of the serology results will develop as evidence is
accumulated on the clinical and immunological features of
SARS-CoV-2 antibodies.
Conclusions
This population-based cohort study with randomly selected
schools and classes across the age range for mandatory
school time offers a unique opportunity to observe the
longitudinal spread of SARS-CoV-2 infection in children
in schools, as well as in their parents and school personnel,
thus studying the whole school community. We will report
SARS-CoV-2 seroprevalence in children by age groups and
regions, provide essential information on possible trans-
mission routes and immunity over time, and assess indi-
vidual and school-level risk factors for infection. The
longitudinal design will allow describing temporal trends
of immunity to SARS-CoV-2 and evaluating effects of
school structure and preventive measures. The results of
the study will inform goal-oriented policy decisions in
school management during subsequent outbreaks.
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